Saniona AB (publ) (STO:SANION)
12.91
-0.14 (-1.07%)
Jun 12, 2026, 5:29 PM CET
Saniona AB Market Cap
Saniona AB has a market cap or net worth of 1.78 billion as of June 12, 2026. Its market cap has increased by 52.08% in one year.
Market Cap
1.78B
Enterprise Value
1.25B
Revenue
429.29M
Ranking
n/a
PE Ratio
8.08
Stock Price
12.91
Market Cap Chart
Since April 22, 2014, Saniona AB's market cap has increased from 71.49M to 1.78B, an increase of 2,392.50%. That is a compound annual growth rate of 30.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.78B | -39.10% |
| Dec 30, 2025 | 2.93B | 223.43% |
| Dec 30, 2024 | 904.76M | 251.84% |
| Dec 29, 2023 | 257.15M | 34.48% |
| Dec 30, 2022 | 191.21M | -65.37% |
| Dec 30, 2021 | 552.11M | -57.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.51B |
| Vicore Pharma Holding AB | 2.98B |
| Egetis Therapeutics AB | 2.46B |
| Flerie AB | 2.01B |
| BioInvent International AB | 1.59B |
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 930.82M |
| Infant Bacterial Therapeutics AB | 821.76M |